Freshfields advised Merz Therapeutics on its $185 million acquisition of Acorda Therapeutics. Merz Therapeutics, a renowned entity in the neurotoxins sector, has entered into an agreement...
Merz Therapeutics’ $185m Acquisition of Acorda Therapeutics
Cazoo’s Restructuring Agreement
Freshfields advised Cazoo in restructuring agreement with key noteholders. Cazoo Group Ltd (NYSE), the leading independent online car retailer in the UK, has successfully concluded a...
SERB Pharmaceuticals’ Partnership with SFJ Pharmaceuticals
Freshfields advised SERB Pharmaceuticals on its U.S. Partnership. SERB Pharmaceuticals, a global specialty pharmaceutical company, has acquired exclusive US rights to the ticagrelor reversal agent bentracimab...
Boxed, Inc.’s Chapter 11 Filing
Freshfields represented Boxed, Inc. Boxed Inc (BOXD.N) filed for Chapter 11 bankruptcy protection and was pursuing sale of its software business, the e-commerce grocery platform said...
Clarke Capital Partners’ Acquisition of Stake in Clear Link Technologies From Sitel Group
Freshfields represented Sitel Group on the deal. Sitel Group, one of the largest global providers of customer experience products and solutions, sold a significant interest in...
Sitel Group’s $2.2 Billion Take-Private of Sykes Enterprises
Freshfields represented Sitel Group on the deal. Shumaker, Loop & Kendrick, LLP acted as legal advisor to Sykes Enterprises. Sitel Group®, a leading global provider of...